Basic info
Industry
biotechnology research
Sectors
Biotechnology
Pharmaceutical
Life Science
Partnering
Cancer
autoimmune
lupus nephritis
IBD
rheumatoid arthritis
psoriasis
inflammation
In-licensing
T-cell lymphoma
Research and Development
Targeted small molecules
Addressing unmet medical needs
lupus
prostate cancer
Medical
AML
B-cell malignancies
Date founded
2012
Funding rounds raised
Total raised
$585K
from 2 investors over 2 rounds
I
Inflection Biosciences Ltd raised $82K on January 1, 2019
Investors: Executive Agency for Small and Medium-sized Enterprises (EASME)
I
Inflection Biosciences Ltd raised $585K on June 1, 2013
Investors: Enterprise Ireland